Skip to main content
. 2019 Nov 8;14:8819–8834. doi: 10.2147/IJN.S217038

Figure 8.

Figure 8

Tube formation inhibition by nanoparticles on HUVECs. (A) Representative images of HUVECs tube formation; (B) Tube formation capacity of HUVECs. Data are expressed as mean ± SD, n = 6. **p < 0.01, ***p < 0.001 vs control; ##p < 0.01, ###p < 0.001 vs eBev-DPPNs.

Abbreviations: eBev-DPPNs, electrostatically-conjugated bevacizumab-bearing DPPNs; cBev-DPNs, chemically-conjugated bevacizumab-bearing DPNs.